Abstract
Eosinophilia in peripheral blood is a common phenomenon associated with atopic condition. The present study illustrates the enhanced sensitivity of these eosinophils for formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF) (measured as luminol-enhanced chemiluminescence) compared with eosinophils located from the peripheral blood of normal individuals. The PAF-induced chemiluminescence, which is peroxidase dependent and of extracellular origin, is inhibited by the PAF antagonist BN52021. The enhanced sensitivity of eosinophils isolated from atopic patients for FMLP and PAF might reflect a 'primed' state of these cells, relevant for the pathogenesis of atopic disease.
Original language | English |
---|---|
Pages (from-to) | 534-536 |
Number of pages | 3 |
Journal | Immunology |
Volume | 67 |
Issue number | 4 |
Publication status | Published - 1 Jan 1989 |